Scientific References:
1. Chen J., Zhang D., Yan W., Yang D., Shen B. Translational Bioinformatics for Diagnostic and Prognostic Prediction of Prostate Cancer in the Next-Generation Sequencing Era. BioMed Res. Int. 2013;2013:901578. doi: 10.1155/2013/901578. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
2. Hjelmborg J.B., Scheike T., Holst K., Skytthe A., Penney K.L., Graff R.E., Pukkala E., Christensen K., Adami H.-O., Holm N.V., et al. The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer. Cancer Epidemiol. Biomark. Prev. 2014;23:2303–2310. doi: 10.1158/1055-9965.EPI-13-0568. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
3. Termini D., Hartogh D.J.D., Jaglanian A., Tsiani E. Curcumin against Prostate Cancer: Current Evidence. Biomolecules. 2020;10:1536. doi: 10.3390/biom10111536. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Wen S., Chang H.-C., Tian J., Shang Z., Niu Y., Chang C. Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer. Am. J. Pathol. 2015;185:293–301. doi: 10.1016/j.ajpath.2014.10.012. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
5. Cittadini A., Isidori A.M., Salzano A. Testosterone therapy and cardiovascular diseases. Cardiovasc.
Res.2021;118:2039–2057. doi: 10.1093/cvr/cvab241. [PubMed] [CrossRef] [Google Scholar]
6. Bluemn E.G., Nelson P.S. The androgen/androgen receptor axis in prostate cancer. Curr. Opin. Oncol. 2012;24:251–257. doi: 10.1097/CCO.0b013e32835105b3. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
7. Ziaran S., Novakova Z.V., Böhmer D., Danišovič L. Biomarkers for determination prostate cancer: Implication for diagnosis and prognosis. Neoplasma. 2015;62:683–691. doi: 10.4149/neo_2015_082. [PubMed] [CrossRef] [Google Scholar]
8. Takayama K.-I. Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling. Biomolecules. 2019;9:131. doi: 10.3390/biom9040131. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
9. Bach C., Pisipati S., Daneshwar D., Wright M., Rowe E., Gillatt D., Persad R., Koupparis A. The status of surgery in the management of high-risk prostate cancer. Nat. Rev. Urol. 2014;11:342–351. doi: 10.1038/nrurol.2014.100. [PubMed] [CrossRef] [Google Scholar]
10. Ziegler A., Koch A., Krockenberger K., Großhennig A. Personalized medicine using DNA biomarkers: A review. Qual. Life Res. 2012;131:1627–1638. doi: 10.1007/s00439-012-1188-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Privacy Policy | Terms
This site is not part, neither is it endorsed by FACEBOOK™.
FACEBOOK™ is a trademark of FACEBOOK™ , Inc.
FDA Compliance
The information on this website has not been evaluated by the Food & Drug Administration or any other medical body. We do not aim to diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. You should always consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication or have a medical condition